Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- المؤلفون: Merck KGaA, Darmstadt, Germany
- المصدر:
A Phase I, Multicenter, Open-Label First in Human Study of Anti-CEACAM5 Antibody Drug Conjugate M9140 in Participants With Advanced Solid Tumors (PROCEADE-CRC-01)
- الدخول الالكتروني :
No Comments.